{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:10:45Z","timestamp":1790244645272,"version":"4.1.0"},"reference-count":29,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background\/Objectives: Chronic graft-versus-host disease (cGVHD) remains a significant complication after allogeneic stem cell transplantation. Bronchiolitis obliterans syndrome (BOS), the best characterized form of pulmonary cGVHD, represents its most severe and therapeutically challenging manifestation and is associated with poor long-term outcomes. However, data on treatment responses and survival remain limited. Methods: We performed a retrospective, single-center study to characterize the clinical features, treatment responses, and survival outcomes of patients with BOS following allo-HSCT. Results: Between January 2003 and December 2023, 28 (4.1%) of 678 transplanted patients met the National Institutes of Health (NIH) diagnostic criteria for BOS with lung scores of 2\u20133. The median age was 26 years (21\u201351), and 67.9% were male. The median time from transplantation to BOS diagnosis was 20.9 months (11.2\u201345.9). Median forced expiratory volume in one second (FEV1) declined from 97.5% at transplantation to 47.5% at BOS diagnosis, while median diffusing capacity for carbon monoxide (DLCO) decreased from 72% to 35% of predicted.The best observed response was partial response (PR). The overall first-line steroid-based response rate was 14.3%. In second- and subsequent-line settings, PR rates were 25% with ibrutinib, 25% with extracorporeal photopheresis, 33.3% with ruxolitinib, and 20% with mesenchymal stem cell therapy, while no responses were observed with imatinib. Median overall survival from transplantation was 90.9 months (48.4\u2013133.5), whereas median survival from BOS diagnosis was 27.2 months (17.4\u2013156.9). Survival after BOS diagnosis was significantly longer in patients with a prior history of acute GVHD (79.7 vs. 25.7 months; p = 0.026) and in those with concomitant extrapulmonary cGVHD compared with isolated BOS (79.7 vs. 7.6 months; p = 0.001). Conclusions: Treatment responses in stage 2\u20133 BOS were limited, and survival remained very poor, highlighting the importance of earlier recognition and more effective therapies before fibrotic progression.<\/jats:p>","DOI":"10.3390\/jcm15197410","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:07:54Z","timestamp":1790240874000},"page":"7410","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bronchiolitis Obliterans Syndrome After Allogeneic HSCT: Clinical Characteristics and Survival Outcomes in a Single Center Cohort"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8295-9431","authenticated-orcid":false,"given":"Emine Merve","family":"Sava\u015f","sequence":"first","affiliation":[{"name":"Department of Hematology, Gazi University Faculty of Medicine; Ankara 06500, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2889-7265","authenticated-orcid":false,"given":"Nurdan","family":"Kokturk","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Gazi University Faculty of Medicine; Ankara 06500, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"supervision","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"given":"Ahmet Alparslan","family":"Ceran","sequence":"additional","affiliation":[{"name":"Department of Hematology, Gazi University Faculty of Medicine; Ankara 06500, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]},{"given":"\u015eeyma","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[{"name":"Department of Hematology, Gazi University Faculty of Medicine; Ankara 06500, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]},{"given":"M\u00fcnevver \u0130rem","family":"K\u00f6k Y\u0131lmaz","sequence":"additional","affiliation":[{"name":"Department of Hematology, Gazi University Faculty of Medicine; Ankara 06500, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"}]},{"given":"Ba\u015fak","family":"Bostankolu De\u011firmenci","sequence":"additional","affiliation":[{"name":"Department of Hematology, Gazi University Faculty of Medicine; Ankara 06500, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]},{"given":"Zeynep Arzu","family":"Ye\u011fin","sequence":"additional","affiliation":[{"name":"Department of Hematology, Gazi University Faculty of Medicine; Ankara 06500, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonca","family":"Erba\u015f","sequence":"additional","affiliation":[{"name":"Department of Radiology, Gazi University Faculty of Medicine; Ankara 06500, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"\u00d6zlem","family":"G\u00fczel Tun\u00e7can","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Gazi University Faculty of Medicine; Ankara 06500, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"supervision","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Aysun","family":"Sar\u0131er","sequence":"additional","affiliation":[{"name":"Department of Hematology, Gazi University Faculty of Medicine; Ankara 06500, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"given":"Z\u00fcbeyde Nur","family":"\u00d6zkurt","sequence":"additional","affiliation":[{"name":"Department of Hematology, Gazi University Faculty of Medicine; Ankara 06500, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"ref_1","first-page":"134","article-title":"Recognizing and managing chronic graft-versus-host disease","volume":"2008","author":"Lee","year":"2008","journal-title":"ASH Educ. Program Book"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood-2014-01-514752","article-title":"Current issues in chronic graft-versus-host disease","volume":"124","author":"Ritz","year":"2014","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1182\/blood-2010-11-319509","article-title":"Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: Report on baseline data from the Chronic GVHD Consortium","volume":"117","author":"Pidala","year":"2011","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1182\/bloodadvances.2021004941","article-title":"Nonrelapse mortality among patients diagnosed with chronic GVHD: An updated analysis from the Chronic GVHD Consortium","volume":"5","author":"DeFilipp","year":"2021","journal-title":"Blood Adv."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41409-019-0771-2","article-title":"Incorporating posttransplant cyclophosphamide-based prophylaxis as standard-of-care outside the haploidentical setting: Challenges and review of the literature","volume":"55","author":"Awol","year":"2020","journal-title":"Bone Marrow Transpl."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/bmt.2011.35","article-title":"Diagnosis and treatment of pulmonary chronic GVHD: Report from the consensus conference on clinical practice in chronic GVHD","volume":"46","author":"Hildebrandt","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.bbmt.2009.11.002","article-title":"Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation\u2014An increasingly recognized manifestation of chronic graft-versus-host disease","volume":"16","author":"Chien","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1038\/s41409-021-01389-5","article-title":"Steroid-refractory chronic graft-versus-host disease: Treatment options and patient management","volume":"56","author":"Wolff","year":"2021","journal-title":"Bone Marrow Transplant."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Jaing, T.H., Wang, Y.L., and Chiu, C.C. (2024). Time to Rethink Bronchiolitis Obliterans Syndrome Following Lung or Hematopoietic Cell Transplantation in Pediatric Patients. Cancers, 16.","DOI":"10.3390\/cancers16213715"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199907013410103","article-title":"Long-term survival and late deaths after allogeneic bone marrow transplantation","volume":"341","author":"Stone","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood.V100.2.406","article-title":"Severity of chronic graft-versus-host disease: Association with treatment-related mortality and relapse","volume":"100","author":"Lee","year":"2002","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1378\/chest.128.1.153","article-title":"Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia","volume":"128","author":"Loberiza","year":"2005","journal-title":"Chest"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1083-8791(03)00242-8","article-title":"Bronchiolitis obliterans in chronic graft-versus-host disease: Analysis of risk factors and treatment outcomes","volume":"9","author":"Dudek","year":"2003","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_16","first-page":"169","article-title":"Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation","volume":"16","author":"Curtis","year":"1995","journal-title":"Bone Marrow Transpl."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbmt.2010.11.018","article-title":"Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation","volume":"17","author":"Au","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1182\/blood-2019-128226","article-title":"Prevalence of Bronchiolitis Obliterans Syndrome (BOS) Following Allogeneic Hematopoietic Stem Cell Transplant (alloHSCT) in the USA, Europe and Japan","volume":"134","author":"Hofstetter","year":"2019","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1038\/s41409-024-02422-z","article-title":"Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens","volume":"59","author":"Rassner","year":"2024","journal-title":"Bone Marrow Transpl."},{"key":"ref_20","first-page":"502.e501","article-title":"Comparison of Pulmonary Toxicity after Total Body Irradiation- and Busulfan-Based Myeloablative Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients","volume":"28","author":"Liu","year":"2022","journal-title":"Transplant. Cell. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood-2014-08-551994","article-title":"How we treat chronic graft-versus-host disease","volume":"125","author":"Flowers","year":"2015","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.2009.1018","article-title":"Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation","volume":"302","author":"Williams","year":"2009","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1182\/bloodadvances.2024014374","article-title":"Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: A multicenter real-world analysis","volume":"9","author":"Pidala","year":"2025","journal-title":"Blood Adv."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1086006","DOI":"10.3389\/fimmu.2023.1086006","article-title":"Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers","volume":"14","author":"Bojanic","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2033122","article-title":"Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease","volume":"385","author":"Zeiser","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1182\/blood.2021012021","article-title":"Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: The ROCKstar Study","volume":"138","author":"Cutler","year":"2021","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJMoa2401537","article-title":"Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease","volume":"391","author":"Wolff","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1701330","DOI":"10.1183\/13993003.01330-2017","article-title":"Lung transplantation after allogeneic stem cell transplantation: A pan-European experience","volume":"51","author":"Greer","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2301727","DOI":"10.1183\/13993003.01727-2023","article-title":"ERS\/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-versus-host disease in adults","volume":"63","author":"Bos","year":"2024","journal-title":"Eur. Respir. J."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7410\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:35:49Z","timestamp":1790242549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":29,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["jcm15197410"],"URL":"https:\/\/doi.org\/10.3390\/jcm15197410","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]}}}